COMPANY DESCRIPTION
Emulate is igniting a new era in human health with industry- leading Organ-on-a-Chip technology. The Human Emulation System provides a window into the inner workings of human biology and disease—offering researchers an innovative technology designed to predict human response with greater precision and detail than conventional cell culture or animal- based experimental testing. Pioneered at the Wyss Institute for Biologically Inspired Engineering at Harvard University and backed by Northpond Ventures, Founders Fund, and Perceptive Advisors, Organ-on-a-Chip technology by Emulate is assisting researchers across academia, pharma, and government industries through its predictive power and ability to recreate true-to-life human biology.
COMPANY BACKGROUND
The pioneering work on Organ-Chips was begun by our founding team at the Wyss Institute for Biologically Inspired Engineering at Harvard University. Following the landmark paper in Science, “Reconstituting Organ-Level Lung Functions on a Chip,” Emulate was founded to share the success of these efforts with the broader life sciences community.
MARKETS SERVED
Emulate provides industry leading Organ-on-a-Chip technology to researchers across academia, government, pharmaceutical, cosmetics, chemicals, and food safety testing entities. Our customers are using the technology across research areas as
diverse as Cancer, Immunology, Infectious Disease, Neuroscience, and Toxicology Safety Testing.
PRODUCTS, SERVICES & CAPABILITIES
• Zoë Culture Module: Seamless Organ-Chip interface allows researchers to avoid complex, manual, and error-prone syringe pump and tubing setups.
• Orb Hub Module: Orb connects to standard lab outputs and provides gas, power, and stretch to up to four Zoë Culture Modules.
• Validated Bio-Kits for brain, intestine, liver, and kidney, in addition to a Basic Research Kit that allows researchers to build their own models.
• Fee-for-Service: Researchers can partner with our in-house scientific experts and gain access to cutting-edge Organ-on-a-Chip technology for target validation, mechanism of action, and advanced in vitro toxicity studies.